Evidence map›Paper›PMID 38664429›Full record

ArticleNature communications2024

Persistent TFIIH binding to non-excised DNA damage causes cell and developmental failure.

Alba Muniesa-Vargas, Carlota Davó-Martínez, Cristina Ribeiro-Silva, Melanie van der Woude, Karen L Thijssen, Ben Haspels, David Häckes, Ülkem U Kaynak, Roland Kanaar, Jurgen A Marteijn and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Topology Resetting During Transcription-Coupled Nucleotide Excision Repair.International journal of molecular sciences · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Alba Muniesa-Vargas *Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.
Carlota Davó-Martínez *Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-7182-6921
Cristina Ribeiro-Silva *Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-2102-1949
Melanie van der WoudeDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.
Karen L ThijssenDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-6136-5164
Ben HaspelsDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Oncode Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.
David HäckesDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.
Ülkem U KaynakDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.ORCID http://orcid.org/0009-0007-8636-9579
Roland KanaarDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Oncode Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.
Jurgen A MarteijnDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Oncode Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0001-9321-518X
Arjan F TheilDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0001-5779-1681
Maayke M P KuijtenDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Oncode Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.
Wim VermeulenDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0003-3616-734X
Hannes LansDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands. w.lans@erasmusmc.nl.ORCID http://orcid.org/0000-0003-4417-5358
Erasmus MC · NL

Funding

Worldwide Cancer Research 15-1274
6 · The paper itself

Abstract

Congenital nucleotide excision repair (NER) deficiency gives rise to several cancer-prone and/or progeroid disorders. It is not understood how defects in the same DNA repair pathway cause different disease features and severity. Here, we show that the absence of functional ERCC1-XPF or XPG endonucleases leads to stable and prolonged binding of the transcription/DNA repair factor TFIIH to DNA damage, which correlates with disease severity and induces senescence features in human cells. In vivo, in C. elegans, this prolonged TFIIH binding to non-excised DNA damage causes developmental arrest and neuronal dysfunction, in a manner dependent on transcription-coupled NER. NER factors XPA and TTDA both promote stable TFIIH DNA binding and their depletion therefore suppresses these severe phenotypical consequences. These results identify stalled NER intermediates as pathogenic to cell functionality and organismal development, which can in part explain why mutations in XPF or XPG cause different disease features than mutations in XPA or TTDA.

Indexed as

Caenorhabditis elegansDNA-Binding ProteinsDNA DamageDNA RepairEndonucleasesTranscription Factor TFIIHAnimalsCaenorhabditis elegans ProteinsDNA Excision Repair Protein ERCC-5HumansMutationNuclear ProteinsProtein BindingTranscription FactorsXeroderma Pigmentosum Group A ProteinCaenorhabditis elegans ProteinsDNA-Binding ProteinsDNA Excision Repair Protein ERCC-5EndonucleasesERCC1 protein, humanNuclear ProteinsTranscription FactorsTranscription Factor TFIIHXeroderma Pigmentosum Group A Proteinxeroderma pigmentosum group F proteinXPA protein, human

Identifiers

PMID38664429
PMCPMC11045817
OpenAlexW4395465085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.